Alo MN, Anyim C, Onyebuchi AK, Okonkwo EC (2012). Prevalence of asymptomatic co-infection of candidiasis and vaginal trichomoniasis among pregnant women in Abakaliki, South-Eastern Nigeria. Prevalence 2(7):87-91.

Achkar JM, Fries BC (2010). Candida infections of the genitourinary tract, Clinical Microbiology Reviews 23(2):253-273.
Crossref

Akah PA, Nnamani CE, Nnamani PO (2010). Prevalence and treatment outcome of vulvovaginal candidiasis in pregnancy in a rural community in Enugu State, Nigeria. Journal of Medicine and Medical Sciences 1(10):447-452.

Aring BJ, Mankodi PJ, Jasani JH (2012). Incidence of vaginal Candidiasis in leucorrhoea in women Attending in OPD of Gynecology and Obstetrics Department. International Journal of Biomedical and Advance Research 3(12):867-869.
Crossref

Arora DR, Arora BB (2014). Medical Parasitology, 4e 4th Edition, Kindle Edition (46):41-71.

Burkhart CN, Burkhart CG (2005). Assessment of frequency, transmission, and genitourinary complications of enterobiasis (pinworms). International journal of dermatology 44(10):837-840.
Crossref

Cheesbrough M (2000). Fungal pathogens. In: District Laboratory Practice in Tropical Countries. Cambridge, UK: Cambridge University Press pp. 235-248.

Demirezen S, Dirlik OO, Beksaç MS (2005). The association of Candida infection with intrauterine contraceptive device. Central European Journal of Public Health 13:32-34.

Dennerstein GJ, Ellis DH (2001). Oestrogen, glycogen and vaginal candidiasis. Australian and New Zealand Journal of Obstetrics and Gynaecology 41(3):326-328.
Crossref

Donders GG, Prenen H, Verbeke G, Reybrouck R (2002). Impaired tolerance for glucose in women with recurrent vaginal candidiasis. American Journal of Obstetrics and Gynecology 187(4):989-993.
Crossref

Emeribe AU, Nasir IA, Onyia J, Ifunanya AL (2015). Prevalence of vulvovaginal candidiasis among nonpregnant women attending a tertiary health care facility in Abuja, Nigeria. Research and Reports in Tropical Medicine 6:37-42.
Crossref

Ferris DG. Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS (2002).Over-the-counter antifungal drug misuse associated with patient diagnosed vulvovaginal candidiasis. Obstetrics Gynecology 99(3):419-425.
Crossref

Foxman B, Barlow RH, D'Arcy H, Gillespie B, Sobel JD (2000). Candida vaginitis: self-reported incidence and associated costs, Sexually Transmitted Diseases 27(4):230-235.
Crossref

Hofs S, Mogavero S, Hube B (2016). Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota. Journal of Microbiology 54(3):149-169.
Crossref

Jombo GT, Opajobi SO, Egah DZ, Banwat EB, Akaa PD (2010). Symptomatic vulvovaginal candidiasis and genital colonization by Candida species in Nigeria. Journal of Public Health and Epidemiology 2(6):147-151.

Kwawukume EY, Arhin RA (2002). Vulvovaginitis. In: Kwawukume EY, Emuveyan EE, editors. Comprehensive Gynaecology in the Tropics.1st ed. Dansoman: Asante and Hittscher pp. 72-74.

Lisiak M, K?yszejko C, Pierzcha?o T, Marcinkowski Z (2000).Vaginal candidiasis: frequency of occurrence and risk factors. Ginekologia polska 71(9):964-970.

Maccato ML, Kaufman RH (1991). Fungal vulvovaginitis. Current opinion in obstetrics and gynecology 3(6):849-852.
Crossref

Mahadani JW, Dekate RR, Shrikhande AV (1998). Diagnosis of discharge per vaginum. Indian Journal of Pathology and Microbiology 41(4):403-411.

McCormack Jr WM, Zinner SH, McCormack WM (1994). The incidence of genitourinary infections in a cohort of healthy women. Sexually Transmitted Diseases 21(2):63-64.
Crossref

Mirza NB, Nsanze H, D'Costa LJ, Piot P (1983). Microbiology of vaginal discharge in Nairobi, Kenya. British Journal on Venereal Diseases 59(3):186-188.
Crossref

Mohamadi J, Havasian MR, Panahi J, Pakzad I (2015). Antifungal drug resistance pattern of Candida. spp isolated from vaginitis in Ilam-Iran during 2013-2014. Bioinformation 11(4):203-206.
Crossref

Mucci MJ, Cuestas ML, Cervetto MM, Landaburu MF, Mujica MT (2016). A prospective observational study of vulvovaginitis in pregnant women in Argentina, with special reference to candidiasis. Mycoses. 59(7):429-435.
Crossref

Nandan D, Gupta YP, Krishnan V, Sharma A, Misra SK (2011) Reproductive tract infection in women of reproductive age group in Sitapur/ Shahjahanpur district of Uttar Pradesh. Indian Journal of Public Health 45(1):8-13.

Nelson M, Wanjiru W, Margaret MW (2013). Prevalence of Vaginal Candidiasis and Determination of the Occurrence of Candida Species in Pregnant Women Attending the Antenatal Clinic of Thika District Hospital, Kenya. Open Journal of Medical Microbiology 3:264-272.
Crossref

Nnadi DC, Singh S (2017). The prevalence of genital Candida species among pregnant women attending antenatal clinic in a tertiary health center in North-west Nigeria. Sahel Medical Journal 20(1):33-37.

Okonkwo NJ (2010). Prevalence of vaginal candidiasis among pregnant women in Nnewi town of Anambra State, Nigeria. African Research Review 24:539-548.
Crossref

Okonofua FE, Ako-Nai KA, Dighitoghi MD (1995). Lower genital tract infections in infertile Nigerian women compared with controls. Genitourinary Medicine 71(3):163-168.
Crossref

Parveen N, Munir AA, Din I, Majeed R (2008). Frequency of vaginal candidiasis in pregnant women attending routine antenatal clinic. Journal of College Physicians and Surgoens Pakistan 18:154-157.

Rathod SD, Klausner JD, Krupp K, Reingold AL, Madhivanan P (2012). Epidemiologic features of vulvovaginal candidiasis among reproductive-age women in India. Infectious Diseases of Obstetrics and Gynecology, 859071.
Crossref

Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Kochupillai N (2007). Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 30(2):312-317.
Crossref

Reed BD, Zazove P, Pierson CL, Gorenflo DW, Horrocks JJ ((2003). Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. Journal of Women's Health 12(10):979-989.
Crossref

Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE (2000). Practice guidelines for the treatment of candidiasis. Clinical Infectious Diseases 30(4):662-678.
Crossref

Roberts CL, Morris JM, Rickard KR, Giles WB, Simpson JM, Kotsiou G, Bowen JR (2011). Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077]. BMC Pregnancy and Childbirth 11(1):1-9.
Crossref

Røttingen JA, Cameron DW, Garnett GP (2001). A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sexually Transmitted Diseases 28(10):579-597.
Crossref

Salvi M (2019). Prevalence of vulvovaginal candidiasis in females in the reproductive age group. International Journal of Reproduction, Contraception Obstetrics and Gynecology 8(2):647-651.
Crossref

Shekufeh P, Minoo M, Rasoul M (2017). Clinical and Mycological study of vulvovaginal candidiasis (VVC), Identification of clinical isolates by polymerase chain-fragment size polymorphyim (PCR-FSP) technique. Archives of Clinical Infectious Diseases 12(2):e62761.

Singh SI (2003). Treatment of vulvovaginal candidiasis. Clinical Review 136(9):26-30.

Sobel JD (2007). Vulvovaginal candidosis. Lancet 369(9577):1961-1971.
Crossref

Sobel TD (1997). Vaginitis. New England Journal of Medicine 337(26):1896-1903.
Crossref

Tarry W, Fisher M, Shen S (2005). Mawhinney M. Candida albicans: The estrogen target for vaginal colonization. Journal of Surgical Research 129(2):278-282.
Crossref

Ugwa EA (2015). Vulvovaginal Candidiasis in Aminu Kano Teaching Hospital, North West Nigeria: Hospital Based Epidemiological Study. Annals of Medical and Health Science Research 5(4):274-278.
Crossref

Yadav K, Prakash S (2016). Prevalence of vulvovaginal candidiasis in pregnancy. Global Journal of Medical Sciences 4(1):108-106.